Skip to main content

Table 1 Tumor types and number of TCGA isomiR samples used in the analysis

From: Tumor classification and biomarker discovery based on the 5’isomiR expression level

Tumor Types # of samples
Adrenocortical carcinoma [ACC] 79
Bladder Urothelial Carcinoma [BLCA] 366
Breast invasive carcinoma [BRCA] 1064
Cervical squamous cell carcinoma and endocervical adenocarcinoma [CESC] 299
Cholangiocarcinoma [CHOL] 35
Colon adenocarcinoma [COAD] 386
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma [DLBC] 46
Esophageal carcinoma [ESCA] 183
Head and Neck squamous cell carcinoma [HNSC] 487
Kidney Chromophobe [KICH] 60
Kidney renal clear cell carcinoma [KIRC] 455
Kidney renal papillary cell carcinoma [KIRP] 261
Acute Myeloid Leukemia [LAML] 105
Brain Lower Grade Glioma [LGG] 497
Liver hepatocellular carcinoma [LIHC] 356
Lung adenocarcinoma [LUAD] 445
Lung squamous cell carcinoma [LUSC] 419
Mesothelioma [MESO] 82
Ovarian serous cystadenocarcinoma [OV] 349
Pancreatic adenocarcinoma [PAAD] 152
Pheochromocytoma and Paraganglioma [PCPG] 178
Prostate adenocarcinoma [PRAD] 472
Rectum adenocarcinoma [READ] 144
Sarcoma [SARC] 243
Skin Cutaneous Melanoma [SKCM] 94
Stomach adenocarcinoma [STAD] 425
Testicular Germ Cell Tumors [TGCT] 149
Thyroid carcinoma [THCA] 483
Thymoma [THYM] 122
Uterine Corpus Endometrial Carcinoma [UCEC] 514
Uterine Carcinosarcoma [UCS] 55
Uveal Melanoma [UVM] 80